- Home
- DRUG vs PKOH Comparison
DRUG vs PKOH Comparison
Compare DRUG & PKOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- PKOH
- Stock Information
- Founded
- DRUG 2019
- PKOH 1907
- Country
- DRUG United States
- PKOH United States
- Employees
- DRUG N/A
- PKOH N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- PKOH Industrial Specialties
- Sector
- DRUG Health Care
- PKOH Industrials
- Exchange
- DRUG Nasdaq
- PKOH Nasdaq
- Market Cap
- DRUG 345.6M
- PKOH 299.9M
- IPO Year
- DRUG N/A
- PKOH N/A
- Fundamental
- Price
- DRUG $55.20
- PKOH $20.43
- Analyst Decision
- DRUG Strong Buy
- PKOH
- Analyst Count
- DRUG 9
- PKOH 0
- Target Price
- DRUG $81.67
- PKOH N/A
- AVG Volume (30 Days)
- DRUG 90.8K
- PKOH 30.9K
- Earning Date
- DRUG 08-11-2025
- PKOH 11-05-2025
- Dividend Yield
- DRUG N/A
- PKOH 2.49%
- EPS Growth
- DRUG N/A
- PKOH 41.57
- EPS
- DRUG N/A
- PKOH 2.02
- Revenue
- DRUG N/A
- PKOH $1,611,500,000.00
- Revenue This Year
- DRUG N/A
- PKOH $0.23
- Revenue Next Year
- DRUG N/A
- PKOH $3.07
- P/E Ratio
- DRUG N/A
- PKOH $7.47
- Revenue Growth
- DRUG N/A
- PKOH N/A
- 52 Week Low
- DRUG $0.94
- PKOH $15.52
- 52 Week High
- DRUG $79.02
- PKOH $34.50
- Technical
- Relative Strength Index (RSI)
- DRUG N/A
- PKOH N/A
- Support Level
- DRUG N/A
- PKOH N/A
- Resistance Level
- DRUG N/A
- PKOH N/A
- Average True Range (ATR)
- DRUG 0.00
- PKOH 0.00
- MACD
- DRUG 0.00
- PKOH 0.00
- Stochastic Oscillator
- DRUG 0.00
- PKOH 0.00
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About PKOH Park-Ohio Holdings Corp.
Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives key revenue from the Supply Technologies segment which includes proactive solutions approach that manages the efficiencies of every aspect of supplying production parts and materials to customers' manufacturing floor, from strategic planning to program implementation.